Both in Pharmaceuticals
Dyne Therapeutics vs Enliven Therapeutics
Over the past year DYN returned −29.8% and ELVN returned +107.4%; their daily moves had a correlation of 0.22.
DYN −29.8% ELVN +107.4%Growth of $1, one year, split-adjusted
| Metric | DYN | ELVN |
|---|---|---|
| Price | $16.98 | $44.39 |
| Market cap | $3.17B | $3.25B |
| Today | +0.21% | +1.60% |
| 1 month | +4.7% | −4.6% |
| 6 months | −2.5% | +4.7% |
| Year to date | −13.2% | +188.2% |
| 1 year | −29.8% | +107.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $685.0M | $895.2M |
| Dividend yield | — | — |
| Volatility (60d) | 58.2% | 39.9% |
| Short % of float | 14.6% | 16.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).